Skip to main content
ISTH 2024 Main banner
Back

Lana A. Castellucci, MD, MSc

MD, MSc
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
Ottawa, Ontario, Canada

Dr. Lana Castellucci is an Associate Professor in the Faculty of Medicine at the University of Ottawa, and a Scientist at The Ottawa Hospital Research Institute (OHRI). She is Chair of the ISTH World Thrombosis Day Steering Committee and Vice-President of Thrombosis Canada, with both organizations promoting education and improved outcomes for patients with venous thrombosis. She is an active member of the CanVECTOR (Canadian Venous Thromboembolism Clinical Trials and Outcomes Research) Network, and is a recipient of the University of Ottawa Tier 2 Research Chair in Thrombosis and Anticoagulation Safety and the Heart and Stroke Foundation of Canada National New Investigator Award.

Dr. Castellucci’s clinical and research interests are focused on the prevention, diagnosis and management of anticoagulant-related bleeding and venous thromboembolism. She is the Principal Investigator of peer-reviewed international clinical trials (funded by the Canadian Institutes of Health Research) Comparison of Bleeding Risk between Rivaroxaban and Apixaban (COBRRA) in patients with acute venous thromboembolism and atrial fibrillation.

Presentation(s):